IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.675
NA - Nord America 5.335
AS - Asia 2.536
AF - Africa 133
OC - Oceania 66
SA - Sud America 63
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.232
SE - Svezia 3.602
RU - Federazione Russa 1.459
SG - Singapore 1.422
IT - Italia 1.418
CN - Cina 465
FI - Finlandia 396
IE - Irlanda 216
DE - Germania 210
IN - India 174
ID - Indonesia 114
JP - Giappone 91
GB - Regno Unito 78
CA - Canada 65
FR - Francia 64
TR - Turchia 60
IR - Iran 58
NL - Olanda 57
AU - Australia 51
ES - Italia 44
NG - Nigeria 43
BR - Brasile 39
MX - Messico 28
HK - Hong Kong 23
EG - Egitto 21
PL - Polonia 19
TW - Taiwan 16
PK - Pakistan 15
GR - Grecia 13
TZ - Tanzania 13
BE - Belgio 12
KR - Corea 12
NO - Norvegia 12
VN - Vietnam 12
DZ - Algeria 11
UA - Ucraina 11
CH - Svizzera 10
NZ - Nuova Zelanda 10
PE - Perù 10
IL - Israele 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
PH - Filippine 8
TH - Thailandia 8
IQ - Iraq 7
KE - Kenya 7
MY - Malesia 7
BD - Bangladesh 6
BG - Bulgaria 6
EU - Europa 6
GH - Ghana 6
HR - Croazia 6
LT - Lituania 6
PT - Portogallo 6
CL - Cile 5
CM - Camerun 5
PG - Papua Nuova Guinea 5
CO - Colombia 4
HU - Ungheria 4
LK - Sri Lanka 4
MW - Malawi 4
PA - Panama 4
TN - Tunisia 4
GN - Guinea 3
JO - Giordania 3
LB - Libano 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BO - Bolivia 2
BY - Bielorussia 2
CU - Cuba 2
GM - Gambi 2
JM - Giamaica 2
LR - Liberia 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
NP - Nepal 2
RE - Reunion 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
ZM - Zambia 2
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
DK - Danimarca 1
EC - Ecuador 1
GT - Guatemala 1
HN - Honduras 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
Totale 15.813
Salva come PNG Salva come JPEG
Città #
Lawrence 1.712
Princeton 1.707
Singapore 810
Moscow 544
Helsinki 388
Milan 383
Ashburn 308
New York 293
Shanghai 243
Dublin 212
Boardman 171
Rome 88
Pune 68
Los Angeles 45
Washington 43
Turin 40
Seattle 37
Borås 36
Florence 33
Sydney 24
Bengaluru 21
Bologna 20
Hanover 20
Istanbul 20
Palermo 19
Paris 19
Pisa 19
Pekanbaru 18
Makassar 17
Bari 16
Jakarta 16
Naples 16
Oldenburg 16
Amsterdam 15
Central 15
Genoa 15
Lagos 15
Rockville 15
Tokyo 15
Dar es Salaam 13
Azzano San Paolo 12
Council Bluffs 12
West Jordan 12
Delhi 11
Ho Chi Minh City 11
Hyderabad 11
Monza 11
Mumbai 11
Abuja 10
Ankara 10
Chicago 10
Perugia 10
Bergamo 9
Cairo 9
Coslada 9
Lima 9
Monterrey 9
Montreal 9
Padova 9
Redwood City 9
San Jose 9
Semarang 9
Tehran 9
Barcelona 8
Berlin 8
Brisbane 8
London 8
Vaprio d'Adda 8
Athens 7
Brooklyn 7
Bursa 7
Chennai 7
Kaohsiung City 7
Katsina 7
Kebumen Satu 7
Nuremberg 7
Pavia 7
St Petersburg 7
Accra 6
Bangkok 6
Castel Gandolfo 6
Catania 6
Cinisello Balsamo 6
Dronten 6
Ferrara 6
Fukushima 6
Hayamiya 6
Isfahan 6
Kish 6
Melbourne 6
Modena 6
Mountain View 6
Perth 6
Santa Maria 6
Tel Aviv 6
Toronto 6
Treviso 6
Trieste 6
Uberaba 6
Ancona 5
Totale 7.996
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 635
Benign Prostatic Hyperplasia and Its Aetiologies 346
Women's sexual dysfunction: a pathophysiological review 231
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 79
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 55
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 54
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 51
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 51
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 50
A propensity score approach for treatment evaluation based on Bayesian Networks 49
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 47
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 44
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 42
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 41
Prediction of Sexual Function After Radical Prostatectomy 40
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 34
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 34
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 33
QUALI SONO I PAZIENTI A RISCHIO DI RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO OLTRE I 10 ANNI DI FOLLOW-UP DOPO PROSTATECTOMIA RADICALE? 32
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 31
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 31
Pelvic lymph node dissection in prostate cancer 31
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 31
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 31
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 30
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 30
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 29
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 29
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 29
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 29
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 29
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 27
ELETTROSTIMOLAZIONE INTRAOPERATORIA DEI NERVI CAVERNOSI CON ELETTRODI IMPIANTABILI 27
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 26
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 26
PRESENTAZIONE CLINICA DELLA INDURATIO PENIS PLASTICA NEI PAZIENTI AL DI SOTTO DEI 40 ANNI 26
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence 26
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 26
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 26
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 26
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 25
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 25
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 25
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 25
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 25
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 25
How to Select the Optimal Candidates for Renal Mass Biopsy 25
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 25
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 24
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer 24
PICCOLE MASSE RENALI: SORVEGLIANZA ATTIVA VS. NEFRECTOMIA 24
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 24
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 24
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 23
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 23
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 23
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial 23
L'INVASIONE ESCLUSIVA DEL COLLO VESCICALE DA CARCINOMA PROSTATICO NON DOVREBBE ESSERE CONSIDERATA COME STADIO PT4 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 23
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 23
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 23
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 23
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 23
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 23
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 22
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 22
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 22
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 22
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 22
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 22
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 21
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 21
External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection 21
A risk calculator predicting recurrence in lymph node metastatic penile cancer 21
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 21
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 21
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 21
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 21
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 21
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 21
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 21
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 20
The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer 20
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 20
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 20
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 20
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 20
Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer 20
Reply by Authors 20
Improving the stratification of intermediate risk prostate cancer 20
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 20
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 20
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 19
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 19
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 19
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 19
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 19
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 19
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 19
Totale 3.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 39 3 1 3 28 3 0 1 5 2 0 0
2020/2021267 0 1 18 3 5 205 4 1 21 6 3 0
2021/20221.070 0 46 34 465 59 58 95 67 33 60 43 110
2022/20238.186 3.963 1.456 485 71 52 806 299 458 256 84 137 119
2023/20243.873 149 212 329 296 296 576 217 374 84 317 466 557
2024/20252.873 2.873 0 0 0 0 0 0 0 0 0 0 0
Totale 16.765